Notice Number: NOT-OD-14-085
Key Dates
Release Date: April 30, 2014
Issued by
National Institutes of Health (NIH)
Purpose
The purpose of this NIH Guide Notice is to notify grantees of changes related to reporting sex/gender, race, and ethnicity information when conducting NIH-defined clinical research. On October 16, 2014, the NIH will transition to a new module within the eRA Commons (known as the Inclusion Management System, or IMS) used for reporting sex/gender, race, and ethnicity information as required by the NIH Policy on the Inclusion of Women and Minorities in Clinical Research (see NOT-OD-14-086). The previous system (known as the Population Tracking System) will be retired this summer.
The NIH is also transitioning to an updated format for reporting sex/gender, race, and ethnicity information. As noted in NOT-OD-13-092, the NIH has modified the format used to report sex/gender, race, and ethnicity information of individuals enrolled in clinical research studies. Applicants submitting competing applications have been using the updated formats starting with receipt dates on or after September 25, 2013.
It is now time to transition to the modified format for Type 5 non-competing progress report submissions using the PHS 2590 or the RPPR (Research Performance Progress Report) as we prepare to deploy the Inclusion Management System.
Transition timeline for new inclusion enrollment reporting format
Awards with start dates BEFORE October 1, 2014 must use the previous inclusion enrollment reporting format.
Awards with start dates AFTER October 1, 2014 must use the updated inclusion enrollment format.
Additional Resources: Additional guidance regarding these changes as well as other topics related to the inclusion of women and minorities in clinical research can be found at: https://grants.nih.gov/grants/funding/women_min/women_min.htm.
Inquiries
Please direct all inquiries to:
Meredith Temple-O'Connor, Ph.D.
NIH Inclusion Policy Officer
Office of Extramural Research
National Institutes of Health
Telephone: 301-435-7124
Email: [email protected]